Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma (Q46118117)

19 December 2017

title

Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma (English)

1 reference

19 December 2017

author name string

E Drakos

1

1 reference

19 December 2017

V Atsaves

2

1 reference

19 December 2017

J Li

3

1 reference

19 December 2017

V Leventaki

4

1 reference

19 December 2017

M Andreeff

5

1 reference

19 December 2017

L J Medeiros

6

1 reference

19 December 2017

G Z Rassidakis

7

1 reference

19 December 2017

publication date

19 February 2009

1 reference

19 December 2017

published in

Leukemia

1 reference

19 December 2017

volume

23

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

784-790

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2008.348

exact match

0 references

cites work

Restoration of p53 function leads to tumour regression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Modeling the therapeutic efficacy of p53 restoration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

The coordinate regulation of the p53 and mTOR pathways in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

The p53-Mdm2 module and the ubiquitin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Establishment and characterization of a new mantle cell lymphoma cell line, Mino

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.348

21 January 2018

Identifiers

DOI

10.1038/LEU.2008.348

1 reference

19 December 2017

PubMed ID

19225536

1 reference

19 December 2017